Related Experiment Video
Updated: Mar 16, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.8K
A new dawn for genetic association studies in multiple sclerosis
1Department of Neurology, Mayo Clinic, Rochester, MN.
Neurology. Genetics
|August 20, 2016
Summary
Genetics research for multiple sclerosis (MS) susceptibility initially used limited knowledge but evolved with genome-wide association studies (GWAS). GWAS identified over 100 MS susceptibility genes, primarily implicating the immune system.
Area of Science:
- Genetics
- Immunology
- Neuroscience
Background:
- Early genetics research for complex diseases like multiple sclerosis (MS) relied on hypothesis-driven candidate gene approaches.
- Genome-wide association studies (GWAS) have revolutionized the discovery of genetic factors influencing MS susceptibility.
- Initial candidate genes, such as HLA-DRB1 and IL7R, were validated and refined by subsequent large-scale genetic studies.
Purpose of the Study:
- To review the evolution of genetic research in identifying multiple sclerosis susceptibility loci.
- To highlight the impact of genome-wide association studies (GWAS) in discovering novel MS risk genes.
- To emphasize the predominant role of the immune system in MS pathogenesis based on genetic findings.
Main Methods:
- Review of historical genetics research methodologies prior to the genomics era.
- Analysis of findings from genome-wide association studies (GWAS) for multiple sclerosis.
- Compilation and categorization of identified MS susceptibility genes.
Main Results:
- Several key genes, including HLA-DRB1 and IL7R, were identified early and confirmed through GWAS.
- GWAS have successfully identified over 100 additional genes associated with MS susceptibility.
- The majority of identified susceptibility genes point towards the immune system as a critical factor in MS.
Conclusions:
- The transition from candidate gene studies to GWAS has significantly advanced the understanding of MS genetic architecture.
- Genetic discoveries consistently implicate immune system dysregulation in the development of multiple sclerosis.
- Continued genetic research is crucial for further elucidating MS pathogenesis and identifying therapeutic targets.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
16.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.5K
01:29Pharmacogenomics: Identification of New Drug Targets
73
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73
01:05Single Nucleotide Polymorphisms-SNPs
19.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.5K